Otsuka licenses Mylan subsidiary to bring MDR TB drug delamanid to India Industry-The Economic Times — August 25, 2017 comments off MDR TB is on the rise in India which, together with China and Russia, accounts for over half of these cases worldwide, according to a recent study.
MDR TB is on the rise in India which, together with China and Russia, accounts for over half of these cases worldwide, according to a recent study.